Study of Residuals Deformities After Diaphyseal Femoral Fracture in Children Treated by Skin Traction

计划入组 53 人 · 首次发布于 2024 年 2 月 7 日

Edwards EVOQUE Eos MISCEND Study

计划入组 123 人 · 首次发布于 2016 年 3 月 24 日

Spine Reference Parameters on EOS Imaging

计划入组 161 人 · 首次发布于 2011 年 8 月 1 日

Eos-003

EOS-301984

EOS-013

Renalytix AI, Inc.

United States

KOS PHARMACEUTICALS

United States

EPS CORPORATION

Japan

Pulmatrix and Eos SENOLYTIX Announce $19 Million Merger to Advance Anti-Aging Mitochondrial Therapies

Empyrean Therapeutics Acquires TLR-2 Antagonist EMS-312 from Eos Therapies to Advance Cancer Treatment

MD Anderson and Phoenix SENOLYTIX Forge Strategic Cross-Licensing Agreement to Advance Injectable Safety Switch Technology for Cell and Gene Therapies